Reportedly, the interaction between the TLR4/NF-κB signaling pathway and HIF-1α contributes to tissue damage and tumor progression in pancreatic ductal adenocarcinoma, oral squamous cell carcinoma, and lung ischemia-reperfusion injury [20–22]. This evidence concerns the gene HIF1A and neoplasm.